We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 0.70% | 35.80 | 35.80 | 36.10 | 36.50 | 35.80 | 36.50 | 253,853 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.61 | 108.56M |
TIDMFUM
RNS Number : 1400K
Futura Medical PLC
06 April 2018
For immediate release 6 April 2018
Futura Medical plc
("Futura" or the "Company")
Notice of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.30pm on 13 June 2018 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
Futura's annual report and accounts for the year ended 31 December 2017 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available at the Company's website www.futuramedical.com, along with the notice of AGM.
Copies of the Annual Report have today been posted to shareholders who have opted out of receiving electronic communications. Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or email tillya@buchanan.uk.com.
For any further information please contact:
Futura Medical plc James Barder, Chief Executive Tel: +44 (0)1483 Angela Hildreth, Finance Director 685 670 and COO mail to: james.barder@futuramedical.com www.futuramedical.com angela.hildreth@futuramedical.com N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 3000 For media enquiries please contact: Buchanan Mark Court / Sophie Wills / Tel: +44 (0)20 7466 Stephanie Watson / Tilly Abraham 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOAUNAARWUASRAR
(END) Dow Jones Newswires
April 06, 2018 07:13 ET (11:13 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions